OncoCyte Corporation, Cornell University License Agreement to Accelerate Lung Cancer Diagnostic Product Development

News   May 27, 2014

 
OncoCyte Corporation, Cornell University License Agreement to Accelerate Lung Cancer Diagnostic Product Development
 
 
 

RELATED ARTICLES

Tweak to Technique Could Bolster Disease Detection

News

A team of Stanford researchers has developed a technique that they hope could more precisely detect diseases or disorders such as cancer or a heart attack.

READ MORE

Immune Cells That Keep Gut Fungi Under Control Identified

News

Immune cells that process food and bacterial antigens in the intestines control the intestinal population of fungi, according to a new study from Weill Cornell Medicine scientists.

READ MORE

New Biomarkers Predict Outcome of Cancer Immunotherapy

News

Researchers at the University of Zurich have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Patients for whom therapy does not work can thus be treated using different methods at an earlier stage.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE